Robert Doebele
Chief Medical Officer · Boundless Bio, Inc.
Individual
- 2026
- Jan 26, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert Doebele files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kevin Tang - $1.57M in BOLD purchases and sales in the last 12 months
- Keith Crandell - $40K in BOLD purchases and sales in the last 12 months
- ARCH Venture Fund IX, L.P. - $40K in BOLD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert Doebele?
Robert Doebele is a corporate insider, tracked as Chief Medical Officer of Boundless Bio, Inc. (BOLD). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Robert Doebele last file a Form 4?
The only primary Form 4 on record is dated 26 January 2026.